The Patent Finder

Vaxil Biotherapeutics Ltd.

Also on record
Records under this name other than the patents Vaxil Biotherapeutics Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 3 of 3 · Back to Vaxil Biotherapeutics Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,179,452Antigen specific multi epitope vaccines
Lapsed on the fee record
Ended Nov 23, 2025 · USPTO record
Lapsed on the fee recordEnded Nov 23, 2025USPTO record
US 9,732,153Antibodies directed against signal peptides, methods and uses thereof
Lapsed on the fee record
Ended Aug 15, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 15, 2025USPTO record
US 9,642,903Antigen specific multi epitope-based anti-infective vaccines
Lapsed on the fee record
Ended May 9, 2025 · USPTO record
Lapsed on the fee recordEnded May 9, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited